Emerging treatments in lung cancer – targeting the RLIP76 molecular transporter
Lawrence E Goldfinger,1,2 Seunghyung Lee1 1Department of Anatomy and Cell Biology, The Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, PA, USA; 2Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, PA, USA Abstract: Multidrug resistance in lung ca...
Saved in:
Main Authors: | Goldfinger LE, Lee S |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/a8ba42b657b9401fb41fbc358a38b57e |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emerging targeted combinations in the management of breast cancer
by: Lee RJ, et al.
Published: (2013) -
Emerging treatment options in the management of non-small cell lung cancer
by: Filosso PL, et al.
Published: (2011) -
Resistance is futile: overcoming resistance to targeted therapies in lung adenocarcinoma
by: Dana S. Neel, et al.
Published: (2017) -
Non-small cell lung cancer: the era of targeted therapy
by: Antonoff MB, et al.
Published: (2012) -
Epiregulin as a therapeutic target in non-small-cell lung cancer
by: Sunaga N, et al.
Published: (2015)